These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22381221)

  • 1. Antimicrobial stewardship: a collaborative partnership between infection preventionists and health care epidemiologists.
    Moody J; Cosgrove SE; Olmsted R; Septimus E; Aureden K; Oriola S; Patel GW; Trivedi KK
    Am J Infect Control; 2012 Mar; 40(2):94-5. PubMed ID: 22381221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant infectious disease: a work in progress.
    Rubin RH
    Transpl Infect Dis; 2005 Jun; 7(2):49-50. PubMed ID: 16150089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of infections with chemotherapeutic agents].
    Lang W
    Munch Med Wochenschr; 1973 Aug; 115(35):1486-9. PubMed ID: 4740820
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.
    Marty FM; Rubin RH
    Transpl Int; 2006 Jan; 19(1):2-11. PubMed ID: 16359371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Preventive Medicine, Public Health and Hygiene (SEMPSPH) for Combating Antimicrobial Resistance.
    Steering Committees of the Spanish Society of Preventive Medicine, Public Health and Hygiene (SEMPSPH) and of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
    Enferm Infecc Microbiol Clin; 2017 Mar; 35(3):139-140. PubMed ID: 28249703
    [No Abstract]   [Full Text] [Related]  

  • 6. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S32-43. PubMed ID: 8547510
    [No Abstract]   [Full Text] [Related]  

  • 7. Policy document on antimicrobial stewardship practices in India.
    Walia K; Ohri VC; Madhumathi J; Ramasubramanian V
    Indian J Med Res; 2019 Feb; 149(2):180-184. PubMed ID: 31219081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; McNeil MM; Schonberger LB; Navin TR; Hanson DL; Gross PA; Jaffe HW
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S1-11. PubMed ID: 8547495
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.
    Stein GE
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):44S-54S. PubMed ID: 16178675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural space infections: microbiology and antimicrobial therapy.
    Everts RJ; Reller LB
    Semin Respir Infect; 1999 Mar; 14(1):18-30. PubMed ID: 10197394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in liver transplant recipients.
    Arslan H
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():24-7. PubMed ID: 24635787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of infectious complications in solid-organ transplant recipients.
    Grim SA; Clark NM
    Clin Pharmacol Ther; 2011 Aug; 90(2):333-42. PubMed ID: 21716270
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic stewardship in the intensive care unit.
    Arnold HM; Micek ST; Skrupky LP; Kollef MH
    Semin Respir Crit Care Med; 2011 Apr; 32(2):215-27. PubMed ID: 21506058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infections in the oncologic patient. Prevention and treatment].
    Cubellos J
    An Esp Pediatr; 1988 Sep; 29 Suppl 33():178-81. PubMed ID: 3074699
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of infections in cancer patients with the help of antimicrobial agents].
    Syrjänen J; Kujala P; Sinisalo M; Lumio J
    Duodecim; 2002; 118(21):2233-9. PubMed ID: 12486960
    [No Abstract]   [Full Text] [Related]  

  • 17. Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders.
    Lehman JS; Murrell DF; Camilleri MJ; Kalaaji AN
    Dermatol Clin; 2011 Oct; 29(4):591-8. PubMed ID: 21925003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
    Moellering RC; Graybill JR; McGowan JE; Corey L;
    Am J Infect Control; 2007 Nov; 35(9):S1-23; quiz S24-6. PubMed ID: 17980231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antimicrobial agents and chemotherapy from 1972 to 1998.
    Swartz MN
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2009-16. PubMed ID: 10898668
    [No Abstract]   [Full Text] [Related]  

  • 20. Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan.
    Tseng SH; Lee CM; Lin TY; Chang SC; Chuang YC; Yen MY; Hwang KP; Leu HS; Yen CC; Chang FY
    J Microbiol Immunol Infect; 2012 Apr; 45(2):79-89. PubMed ID: 22483434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.